alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.1






NOTE




	 	 	 	 	 
	Date:
	 	October 28, 2008
	Maker: Claimsnet.com, Inc.

	Payee:
	 	National Financial Corporation
	Place for Payment:
	 	14860 Montfort Dr., Suite 250, Dallas, TX  75254
	Principal Amount:
	 	Fifty Thousand U.S. dollars (USD$50,000.00)






Annual Interest Rate on Unpaid Principal from Date of Funding: Five percent (5%)



Terms of Payment: Principal and interest shall be due and payable on demand, interest being
calculated on the unpaid principal balance to the date of each installment paid, and the payment
made credited first to the discharge of interest accrued and the balance to the reduction of the
principal. Accrued and unpaid interest shall be computed on the basis of the actual days elapsed
in a year consisting of 365 days on the principal.



Annual Interest Rate on Demanded, Unpaid Amounts: The highest rate allowed by law.



Security for Payment: None



Maker promises to pay to the order of Payee at the place for payment and according to the
terms of payment the principal amount plus interest at the rates stated above. All unpaid amounts
shall be due upon demand.



On default in the payment of this note or in the performance of any obligation in any
instrument securing or collateral to it, this note and all obligations in all instruments securing
or collateral to it shall become immediately due at the election of Payee. Maker and each surety,
endorser, and guarantor waive all demands for payment, presentations for payment, notices of
intention to accelerate maturity, notices of acceleration of maturity, protest, and notices of
protest.



If this note or any instrument securing or collateral to it is given to an attorney for
collection or enforcement, or if suit is brought for collection or enforcement, or if it is
collected or enforced through probate, bankruptcy, or other judicial proceeding, then Maker shall
pay Payee reasonable attorney’s fees in addition to other amounts due. Reasonable attorney’s fees
shall be 10.0% of all amounts due unless either party pleads otherwise.



Nothing in this note shall authorize the collection of interest in excess of the highest rate
allowed by law.



Maker reserves the right to prepay the outstanding principal balance of this Note, in whole or
in part, at any time and from time to time, without premium or penalty. Any such pre-payment shall
be made together with payment of interest accrued on the amount of principal being prepaid through
the date of such prepayment, and shall be applied to the installments of principal due hereunder in
the inverse order of maturity.



Each Maker is responsible for the entire amount of this note.



The terms Maker and Payee and other nouns and pronouns include the plural if more than one.



Maker shall not be deemed to be in default of this note unless and until Maker shall have been
given seven (7) days written notice and opportunity to cure such default, via certified mail return
receipt requested.



Claimsnet.com, Inc.



By:  /s/ Don Crosbie



Don Crosbie, CEO



MAKER
# CE2004078EN.01064103.xml

| 27.3.2004 | EN | Official Journal of the European Union | CE 78/641 |
| --- | --- | --- | --- |

27.3.2004

EN

Official Journal of the European Union

CE 78/641

---

(2004/C 78 E/0680)

WRITTEN QUESTION E-3757/03

by Roberta Angelilli (UEN) to the Commission

(10 December 2003)

Subject:   Update on use of funding from the 2000 City Twinning Programme by the municipality of Pesaro

Subject:

In its answer to question E-1024/03 (1), which asked whether the municipality of Pesaro had submitted projects and secured funding under the 2000 City Twinning Programme, the Commission stated that no funding had been granted for the year 2000.

1

Can the Commission say whether the municipality has submitted any projects and obtained and used any funding in the budget years since then?

---

(1)  OJ C 242 E, 9.10.2003, p. 208.

1

---
- -~-- . 

REF ID:A63401 

llr. Alt"'4 '1'1•Ddl1' 

An1Ran\ Kue&SDS 141tor 

\'be ~ ron u11 ~ Benld 

1'l' L ftreet1 •• v. ~5, p. c. 

r.:r Alt 

,.. pud.INd, x - lenc!iDS 10U., file Cll DIV'8J&P8r and 

JG"lodlaeJ. CliW1rJca OD tba ~ oaM. ._ ell~ 

.. n1u arri'YS»C, aae tit! two bav1tls OGll9 w .. Ju.tt 1bJ.at 

llf'tmlaonJ but % 4au.l>t -~ 1ibe la~• 11.ttc' 'thU v:Ul 

coata1n _, utGnatioc or •i01t1c:an.ce ~ ~ :&a tbe 

tile. 

WblA the tile ... MrV-4 10Ul" JQX'POBel, pl ... lat - or.., ottt.ce Jaiov ..s. w•u ~ 80llleOiDe w pick 1t up .. 

%• w.a ras.ee to 1-ft JOll u .,. au.en at ~ eoaoe 

Clllb 

~ 

1Utftt!q• Geoeral. CaidDO "°tu• S. •eni.Uiaa 10\l ... Uaip. 

@'pp roved for Release by NSA on 06-19-2014 pursuantto E .0. 1352a
<PAGE>   1


                                                                 EXHIBIT  10.70


                        AMENDMENT TO EMPLOYMENT AGREEMENT

         This Amendment to Employment Agreement (the AAmendment@) is made this
1st day of April, 1997, by and between Caraco Pharmaceutical Laboratories, Ltd.
(the "Company") and Robert Kurkiewicz ("Employee").


                                   WITNESSETH:

         WHEREAS, the Company and Employee entered into that certain Employment
Agreement dated October 22, 1993 (the "Employment Agreement");

         WHEREAS, Sun Pharmaceutical Industries Limited ("Sun") has indicated
that it intends to contribute $7.5 million to the Company for 5.3 million shares
of the Company's Common Stock pursuant to a stock purchase agreement (the "Stock
Purchase Agreement");

         WHEREAS, Sun's capital contribution pursuant to the Stock Purchase
Agreement is dependent, among other things, on reductions in Company expenses
and reductions in capital; and

         WHEREAS, Employee recognizes the importance of Sun's capital
contribution to the Company pursuant to the Stock Purchase Agreement, and agrees
to accommodate Sun's need for reductions in the Company's expenses and capital
through modification of his Employment Agreement.

         NOW, THEREFORE, in consideration of the premises and covenants herein
contained, the parties covenant and agree that the following shall become
effective on the date that Sun and the Company execute the Stock Purchase
Agreement.

         1. Salary Reduction. Paragraph 3(a) of the Employment Agreement is
hereby amended by reducing the annual salary payable to Employee from $123,000
to $92,250. Except for the change in the amount of the annual salary, the
provisions of Paragraph 3(a) continue in full force and effect.

         2. Termination Without Cause.Subparagraphs 7(c)(ii)(a), (b) and (c) of
the Employment Agreement are hereby amended by changing the applicable period
over which the severance package is to be paid from twelve (12) months to six
(6) months. Except for this change, the provisions of Subparagraphs 7(c)(ii)(a),
(b) and (c) continue in full force and effect.



<PAGE>   2



         3. Existing Employment Agreement. Except as modified hereby, the terms
and conditions of the Employment Agreement shall continue in full force and
effect.

         IN WITNESS WHEREOF, the Employee and the Company have executed this
Agreement on the date first above written.


CARACO PHARMACEUTICAL LABORATORIES, LTD.,
a Michigan corporation


By:
   ----------------------------------
         William R. Hurd
    Its:  President


EMPLOYEE:


-------------------------------------
Robert Kurkiewicz






                                       2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [B-83-2014]

On November 3, 2014, the Puerto Rico Industrial Development Company, grantee of FTZ 7, submitted a notification of proposed production activity to the Foreign-Trade Zones (FTZ) Board on behalf of IPR Pharmaceuticals, Inc., located within FTZ 7, in Canóvanas, Puerto Rico.

                    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the                     **Federal Register**                     inviting public comment (79 FR 69832, November 24, 2014). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board's regulations, including Section 400.14.                

Dated: March 3, 2015.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2015-05489 Filed 3-6-15; 8:45 am]

 BILLING CODE 3510-DS-P
---

|Delaware                                       | 0-22790              | 42-1410788                        
|---------------------------------------------- | -------------------- | ----------------------------------
|(State or other jurisdiction of incorporation) | (CommissionFile No.) | (IRS EmployerIdentificationNumber)

|13523 University Avenue, Des Moines, Iowa | 50325     
|----------------------------------------- | ----------
|(Address of principal executive offices)  | (Zip Code)

---

---

---

ITEM  5.  OTHER EVENTS.

On June 14, 2001, the Registrant issued the press release attached hereto as Exhibit 99.

ITEM  7.  FINANCIAL STATEMENTS AND EXHIBITS.

(c)	Exhibits:

Exhibit 99 - Press Release dated June 14, 2001

---



Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned thereunto duly authorized.

| | **STATEFED FINANCIAL CORPORATION**
| | ----------------------------------

|Date:     June 15, 2001 | By:   /s/ Andra K. Black       Andra K. Black, Co-President and CFO
|----------------------- | -------------------------------------------------------------------

---



|Exhibit No. | Description                      
|----------- | ---------------------------------
|99          | Press Release dated June 14, 2001
EXHIBIT 32.1

Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-K of SatCon Technology Corporation (the "Company") for the fiscal year ended
December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C.
Section 1350, that:



This
certification is being furnished as an exhibit to the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except to the extent that the Company
specifically incorporates this certification by reference.

|Dated: March 31, 2008 |  | /s/DAVID B. EISENHAUREDavid B. Eisenhaure
President and Chief Executive Officer
|--------------------- |  | -------------------------------------------------------------------------------
|Dated: March 31, 2008 |  | /s/DAVID E. O'NEILDavid E. O'Neil
Vice President of Finance and Treasurer      

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise
adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
**EXHIBIT 23.1**

**CONSENT OFINDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

Wehave issued our reports, dated March 23, 2007, accompanying theconsolidated financial statements and schedule included in the Annual Report ofSatCon Technology Corporation on Form 10-K for the year ended December 31,2006. We hereby consent to the incorporation by reference of said reports inthe Registration Statements of SatCon Technology Corporation on Form S-8(File Nos. 033-75934, 333-04280, 333-08047, 333-75339,333-43802, 333-67504, 333-100753, 333-125882 and 333-125883)and Form S-3 (File Nos. 333-05939, 333-37921, 333-87157,333-94859, 333-48936, 333-67328, 333-103950, 333-111522,333-116533, 333-128527, 333-136673 and 333-139897).
| /s/  VITALE, CATURANO & COMPANY LTD. |   |
|-----------------------------------------------|--------|
| Boston, Massachusetts                         |   |
| March 30, 2007                           |   |

 

----
ex46seniordebtdenture.htm






Exhibit 4.6












THE FIRST BANCORP, INC., ISSUER


and


[              ],


TRUSTEE







INDENTURE


Dated as of [         ], 201[ ]







Senior Debt Securities
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>               DEC-31-1996               
<PERIOD-START>                  JAN-01-1996              
<PERIOD-END>                    DEC-31-1996             
<CASH>                          664434               
<SECURITIES>                    0               
<RECEIVABLES>                   15923533               
<ALLOWANCES>                    117803           
<INVENTORY>                     0               
<CURRENT-ASSETS>                0               
<PP&E>                          0               
<DEPRECIATION>                  0              
<TOTAL-ASSETS>                  16753700            
<CURRENT-LIABILITIES>           0               
<BONDS>                         0               
<PREFERRED-MANDATORY>           2049042              
<PREFERRED>                     0               
<COMMON>                        0              
<OTHER-SE>                      14704658              
<TOTAL-LIABILITY-AND-EQUITY>    16753700               
<SALES>                         0              
<TOTAL-REVENUES>                1726635               
<CGS>                           0               
<TOTAL-COSTS>                   249089              
<OTHER-EXPENSES>                0               
<LOSS-PROVISION>                55383               
<INTEREST-EXPENSE>              191256               
<INCOME-PRETAX>                 1230907               
<INCOME-TAX>                    0               
<INCOME-CONTINUING>             1230907               
<DISCONTINUED>                  0              
<EXTRAORDINARY>                 0               
<CHANGES>                       0               
<NET-INCOME>                    1230907              
<EPS-PRIMARY>                   .00               
<EPS-DILUTED>                   .00               
        


</TABLE>
.. RE D:A65840 

MEMO ROUTING SLIP .,. NEPER USE FOR APPROJIALS. DISAPPROVALS, 

CONCURRENCES, OR SIMILAR ACTIONS 

006 t NAME OR TITLE. 

.;. 

ORGANIZATION AND LOCATION 

2 

3 

4 

INITIALS 

DATE 

CIRCULATE 

COORDINATION 

FILE 

INFORMATION 

NECESSARY ACTION 

NOTE AND RETURN 

SEE ME 

SIGNATURE 

eclassified and approved for release by NSA on 04-29-2014 

ursuantto E.O. 13526 

FROM NAME OR TITLE 

ORGANIZATION AND LOCATION 

Replaces D.'I. A\JU Form89S, l A11r 48,and A.FB.Q Form 12, 10 Nov t~. which may be used.. 

~TE 

-~ ... J 

____ ..,__ 

GP'> ID:iol - 0 SIZftSGC 
I>r. 11.J. EelliY. 

Pre11d.ent. Bell felephaaa l&boratw1••• Im •• 

685 We•t streo~, 

... York. lew Tork 

:0.ar »zo. Z-.1~ I 

<lie ot 'the Garen.~'• 1101t Saportant aour"9 at 1atonatlon. 

toi-miq the b&.11 tor the produoticm ot bip..lnwl lntellii•noe ot i . . . I 

all sorta .!A the Anaed POJ"Oe• Seouriv Apmq (USA}. whot1• pre••nt I 

Dinotor 1a ~ar Admiral I.E. Stcme. lJSI. 

A nry.11all group ot oC.ultanta 1• now boin; orpmaed llZldel" 

tm au.pioe• ot tlw Re1earoh am X.volopnt Baard1 Depa:rtmont ot 

Deteme, to ~•i•t APB.A. in ito atte.mpta to •olw CMJ"taln FObleu. I 

ot a aoet import.ant and \\l"pnt obaraoter. Ada1:ral stQQ& 1-• lndi• 

•ted to• t~t the Rl'8tcth ot thia DD voup ot oomultant• I 

aalled tbo 8poo1e.l Ceyptologlo Adviaoey Qroup (BClG) would be I , 

•tor1a111° eDlmloed by tho add1ticm. ot Dr. OtrE• Sl».mlon., ot 7our 

Iaboratori••• to lts present •mber•h1p. u indS.oated in tbs emlOI~ 

! 

to thi• latter. X roallq.t ot oour••• that :you ban alreadf been good - . eaough to perJd.t Dr. R,.I. Potter. or your Laborator~··. to ••"9 OD. I 

SCA.G and tbat ,ti.retore ;you af be l"81uotant to _pend.t t.o ot the ao1t I 

I 

•luable ••bDn ot the I.a'borator1ea to tornt cm ti:. ,.._ aclrl• aq body. I 

I 

IAmiral Stcmo '.t••la• hOflOver, that Dr. S~on, by virtuo ot hi• 

! ~ 

outatandin,c poa!ti0i., in "ibo o•wuunSoatiODI re1eal'Qb t1eldt oould -- wah 

I 

•1cn1t1oant :1 yaluab1e o~r1buti~~o ~ .~obleu \lllder atud;y 

tm.t a reque1t to ;you to •1ft tho latter ooi.ido.rat1an would" 

I • ' 

appropr1Ate. ~~ 1°" oan do to malm Dr. Sha.mum•• :pa.rtS.Oipation 

i ) ori SOJ.G poad.ble would be great:Jr appreoiatecl. i 

Uli~FIDENllAb 

. ' .-!3° "'- I) •-ti; • ,.., • P' 

---~ 

... 

- ·--'::J 

f 

--.... 

.;; 

- .
<TABLE> <S> <C>

<ARTICLE>         9
<MULTIPLIER>                                1,000

<S>                                        <C>
<PERIOD-TYPE>                               3-MOS
<FISCAL-YEAR-END>                           DEC-31-2000
<PERIOD-START>                              JAN-01-2000
<PERIOD-END>                                MAR-31-2000
<CASH>                                              449
<INT-BEARING-DEPOSITS>                           83,606
<FED-FUNDS-SOLD>                                      0
<TRADING-ASSETS>                                      0
<INVESTMENTS-HELD-FOR-SALE>                      68,304
<INVESTMENTS-CARRYING>                                0
<INVESTMENTS-MARKET>                                  0
<LOANS>                                       1,135,239
<ALLOWANCE>                                      11,547
<TOTAL-ASSETS>                                1,405,928
<DEPOSITS>                                      939,514
<SHORT-TERM>                                    259,834
<LIABILITIES-OTHER>                              12,266
<LONG-TERM>                                       7,217
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<COMMON>                                            300
<OTHER-SE>                                      189,513
<TOTAL-LIABILITIES-AND-EQUITY>                1,405,928
<INTEREST-LOAN>                                  35,366
<INTEREST-INVEST>                                 2,287
<INTEREST-OTHER>                                      0
<INTEREST-TOTAL>                                 37,653
<INTEREST-DEPOSIT>                               13,782
<INTEREST-EXPENSE>                               17,275
<INTEREST-INCOME-NET>                            20,378
<LOAN-LOSSES>                                       624
<SECURITIES-GAINS>                                    0
<EXPENSE-OTHER>                                   2,149
<INCOME-PRETAX>                                  16,998
<INCOME-PRE-EXTRAORDINARY>                       16,998
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                     16,816
<EPS-BASIC>                                     56.05
<EPS-DILUTED>                                     56.05
<YIELD-ACTUAL>                                     6.00
<LOANS-NON>                                      76,193
<LOANS-PAST>                                          0
<LOANS-TROUBLED>                                      0
<LOANS-PROBLEM>                                       0
<ALLOWANCE-OPEN>                                 12,344
<CHARGE-OFFS>                                     2,304
<RECOVERIES>                                        883
<ALLOWANCE-CLOSE>                                11,547
<ALLOWANCE-DOMESTIC>                             11,547
<ALLOWANCE-FOREIGN>                                   0
<ALLOWANCE-UNALLOCATED>                               0


</TABLE>
---

|Delaware                                       | 0-277716             | 13-3870836                        
|---------------------------------------------- | -------------------- | ----------------------------------
|(State or other jurisdiction of incorporation) | (CommissionFile No.) | (IRS EmployerIdentificationNumber)

|6 Executive Plaza, Yonkers, New York     | 10701     
|---------------------------------------- | ----------
|(Address of principal executive offices) | (Zip Code)

---

---

ITEM  5.  OTHER EVENTS.

On October 25, 2000, the Registrant issued a press release reporting increases of 17.9% in net income and 37.8% in diluted earnings per share for the year ended September 30, 2000 and declaring a quarterly
cash dividend of $0.09 per share.  The Registrant also announced that its annual meeting date is scheduled for Thursday, January 25, 2001.

**The foregoing information does not purport to be complete and is qualified in its entirety by reference to the press release attached as an exhibit to this Form 8-K and incorporated by reference herein.**

ITEM  7.  FINANCIAL STATEMENTS AND EXHIBITS.

(c)	Exhibits:

> Exhibit 99 - Press Release dated October 25, 2000



Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned thereunto duly authorized.

| | **YONKERS FINANCIAL CORPORATION**
| | ---------------------------------

|Date:     October 27, 2000 | By:   /s/ Richard F. Komosinski       Richard F. Komosinski  
     President
|-------------------------- | ----------------------------------------------------------------------------



|Exhibit No. | Description                         
|----------- | ------------------------------------
|99          | Press Release dated October 25, 2000